Pseudobulbar affect after stroke: a narrative review

被引:9
作者
Girotra, Tarun [1 ]
Lowe, Forrest [1 ]
Feng, Wuwei [1 ]
机构
[1] Med Univ South Carolina, Dept Neurol, 19 Hagood Ave Suite 501, Charleston, SC 29425 USA
关键词
Stroke; pseudobulbar affect; emotion incontinence; epidemiology; pathophysiology; clinical presentation; treatment; POSTSTROKE DEPRESSION; EMOTIONAL INCONTINENCE; DOUBLE-BLIND; DEXTROMETHORPHAN/QUINIDINE; NEUROANATOMY; VALIDATION; FLUOXETINE; LABILITY; SCALE;
D O I
10.1080/10749357.2018.1499300
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Background: Pseudobulbar affect (PBA) is a neuropsychological condition of emotional lability and affective dysregulation associated with a variety of neurological conditions such as stroke, traumatic brain disease, and neurodegenerative disease. The true prevalence and medico-social burden of PBA associated with stroke is unclear. Often confused with post-stroke mood disorders, PBA is under-recognized and under-treated. Objective: To provide a comprehensive narrative synthesis of published literature on the topic of PBA. Methods: Literature review was performed by searching the key words "pseudobulbar atrophy", "emotional incontinence," and "stroke" in PubMed. Only manuscripts published in English were appraised and relevant content was extracted, synthesized, and summarized. Results: A narrative overview was performed on the following topics: epidemiology, pathophysiology, clinical features of differential diagnosis, impact on public health, and therapeutic options. Conclusion: PBA remains an under-treated condition with significant psychosocial burden on both effected stroke survivors and their families. Advances have been made in developing consensus-based clinical diagnostic criteria for PBA. Early identification and prompt initiation of therapeutic measures are required in these stroke patients. Further research is needed to develop better PBA diagnostic criteria and more cost-effective therapeutic treatment options.
引用
收藏
页码:610 / 616
页数:7
相关论文
共 40 条
[1]   CITALOPRAM FOR POSTSTROKE PATHOLOGICAL CRYING [J].
ANDERSEN, G ;
VESTERGAARD, K ;
RIIS, JO .
LANCET, 1993, 342 (8875) :837-839
[2]  
[Anonymous], 2013, DIAGNOSTIC STAT MANU
[3]  
[Anonymous], 2010, NUED DEXTR HYDR QUIN
[4]  
[Anonymous], 1969, HDB CLIN NEUROLOGY
[5]  
Arciniegas David B, 2005, Am J Geriatr Pharmacother, V3 Suppl A, P4, DOI 10.1016/S1543-5946(05)80031-5
[6]   PRISM: A Novel Research Tool to Assess the Prevalence of Pseudobulbar Affect Symptoms across Neurological Conditions [J].
Brooks, Benjamin Rix ;
Crumpacker, David ;
Fellus, Jonathan ;
Kantor, Daniel ;
Kaye, Randall E. .
PLOS ONE, 2013, 8 (08)
[7]  
Brooks BR, 2004, NEUROLOGY, V63, P1364
[8]   Fluoxetine as a treatment for post-stroke emotionalism [J].
Brown, KW ;
Sloan, RL ;
Pentland, B .
ACTA PSYCHIATRICA SCANDINAVICA, 1998, 98 (06) :455-458
[9]  
Burns A, 1999, INT J GERIATR PSYCH, V14, P681, DOI 10.1002/(SICI)1099-1166(199908)14:8<681::AID-GPS49>3.0.CO
[10]  
2-Z